Drug Development - Existing Targets Milestones
5.A-5.E
No filters selected
ID
Title
Status
5.A
Drug Development/Existing Targets: Phase 1 trials
Initiate first in human, Phase 1 drug trials for therapeutic agents against at least 6 existing therapeutic targets…
Status
In Progress
5.B
Drug Development/Existing Targets: Phase 2 trials
Initiate Phase 2 (proof of concept) drug trials for agents against 3-6 currently known therapeutic targets…
Status
In Progress
5.C
Drug Development/Existing Targets: Phase 3 trials
Initiate Phase 3 drug trials for agents against at least 3 currently known therapeutic targets…
Status
In Progress
5.D
LBD: Clinical trials
Prepare for and initiate clinical trials that aim to alleviate or slow the course of LBD symptoms, and delay or prevent the onset of disease.
Status
In Progress
5.E
Drug Development/Existing Targets: Develop disease-modifying interventions for LBD based on discovering biomarkers, molecular targets, and genetic and environmental modifiers that enhance, delay, or prevent the onset of disease
Develop disease-modifying interventions for LBD based on discovering biomarkers, molecular targets, and genetic and environmental modifiers that enhance, delay or prevent the onset of disease.
Status
In Progress